MicroRNA Assay for Detection and Management of Pancreatic Cancer Precursors
Copyright © Targeted News Service 2024
2024-10-29
ALEXANDRIA, Virginia, Oct. 29 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., Tampa, Florida has been assigned a patent (No. US 12129522 B2, initially filed July 29, 2022) developed by three inventors Mokenge P. Malafa, Tampa, Florida; Jennifer Permuth, Tampa, Florida; and Dung-Tsa Chen, Tampa, Florida, for "MicroRNA assay for detection and management of pancreatic cancer precursors." . . .